The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBaillie Gifford Japan Trust PLC Regulatory News (BGFD)

Share Price Information for Baillie Gifford Japan Trust PLC (BGFD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 734.00
Bid: 732.00
Ask: 736.00
Change: -1.00 (-0.14%)
Spread: 4.00 (0.546%)
Open: 736.00
High: 736.00
Low: 727.00
Prev. Close: 735.00
BGFD Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Baillie Gifford Japan Trust PLC Half-year Report

23 Mar 2022 07:00

RNS Number : 6717F
Baillie Gifford Japan Trust PLC
23 March 2022
 

RNS Announcement

 

The Baillie Gifford Japan Trust PLC

 

Results for the six months to 28 February 2022

Legal Entity Identifier: 54930037AGTKN765Y741

Regulated Information Classification: Interim Financial Report.

 

The following is the unaudited Interim Financial Report for the six months to 28 February 2022.

 

In the six months to 28 February 2022, The Baillie Gifford Japan Trust's net asset value per share decreased by 14.8% compared to a 4.9% decrease in the TOPIX total return (in sterling terms). The Company's share price fell by 18.3% as the shares moved from a premium to a discount to NAV. Over three years to the end of February, the NAV total return was 24.2% and over five years 43.7% compared to the TOPIX return of 20.6% and 24.0% respectively.

 

· Over the six-month period, higher growth businesses have generally been out of favour as the market has focussed on post-pandemic economic recovery

· The three largest detractors from performance were Raksul, GA Technologies and Sysmex

· The largest positive contributors to performance were Inpex and Sumitomo Metal Mining

· The Managers believe that the Company has a well diversified portfolio of quality growth companies with sound long-term prospects available at particularly attractive valuations.

 

Summary of Unaudited Results

 

 

 

28 February

2022

 

31 August

2021

 

 

% change

Shareholders' funds

£809.6m

£955.4m

 

Net asset value per share*

858.3p

1,012.8p

(15.3)

Share price

830.0p

1,022,0p

(18.8)

(Discount)/premium*

(3.3%)

0.9%

 

Active share*

81%

81%

 

 

 

Six months to

28 February 2022

Six months to

28 February 2021

Total returns (%)

 

 

Net asset value per share*

(14.8)

20.4

Share price

(18.3)

30.3

TOPIX total return (in sterling terms) #

(4.9)

11.0

 

 

Six months to 28 February 2022

Six months to 28 February 2021

 

Revenue earnings per share

5.17p

3.40p

 

Six months to 28 February 2022

Year to 31 August 2022

 

Period's high and low

High

Low

High

Low

Net asset value per share*

1,095.6p

829.5p

1,081.3p

841.8p

Share price

1,106.0p

795.0p

1,132.0p

823.0p

Premium/(discount)*

3.2%

(4.7%)

5.5%

(10.3p)

        

 

* Alternative performance measures, see Glossary of Terms and Alternative Performance Measures at the end of this announcement.

# Source: Baillie Gifford/Refinitiv and relevant underlying data providers. See disclaimer at end of this announcement.

 

Interim Management Report

 

During the six months to the end of February 2022 the NAV total return of your Company decreased by 14.8% whilst the share price fell by 18.3% as the shares moved from a premium to a discount to NAV. The TOPIX fell by 4.9% on a total return basis. During the period smaller and higher growth businesses have generally been out of favour as the market has focused on post-pandemic economic recovery. However, we would note, as we did last year in positive circumstances, that six months is a very short timeframe. In our view it is more helpful to consider investment over a longer time horizon, which allows time for business fundamentals to dominate sentiment. Over three years to the end of February, the NAV total return was 24.2% and over five years 43.7% compared to the TOPIX return of 20.6% and 24.0% respectively.

 

The three largest negative contributors to performance were Raksul (-1.1%), GA Technologies (-0.9%) and Sysmex (-0.8%). Raksul operates online services offering printing, on-demand logistics and advertising - securing unused capacity in its target industries and offering it to clients at competitive rates. We continue to believe that the company has a large growth opportunity ahead and the management capabilities to seize them. GA Technologies is attempting to automate various real-estate processes. It has been investing heavily to strengthen its software development capabilities, resulting in near-term operating losses. We believe that this is the correct approach for management to take to maximise the long-term growth opportunity. Sysmex is a very long-standing holding that focuses on blood analysis and has made a large positive contribution to performance in the past but short-term concerns relating to China have resulted in share price weakness. The use of gearing also made a negative (-1.9%) contribution.

 

On the positive side the largest contributors were Inpex (+1.2%) and Sumitomo Metal Mining (+0.9%). Inpex benefitted from the confluence of successful production from its Ichthys LNG project and stronger energy demand from post-pandemic economic recovery. Sumitomo Metal Mining benefitted from higher copper, nickel and gold prices. Copper and nickel are key for electrification and batteries respectively making them important to green energy development. Meanwhile Russia's invasion of Ukraine has resulted in a spike in energy and nickel prices, influencing both holdings.

 

During the period we bought four new holdings and sold seven holdings. Turnover remained low in line with our long-term time horizon. The new holdings are Nintendo, Shiseido, Chugoku Marine Paints and Shima Seiki. As is typical for our flexible growth style, the new holdings operate across a range of industries and include companies of a variety of sizes, including the small. Nintendo has some of the most iconic characters in the gaming world, such as Mario and Zelda. We believe that ongoing developments in gaming will allow greater value to accrue from this intellectual property. Shiseido has Japan's best skincare franchise and is particularly strong in China. This means that it should be able show significant growth over a very long-term time horizon. Chugoku Marine Paints does what it says on the tin, providing value-added paint for ships that helps to reduce their drag through the water. Finally, Shima Seiki makes automated knitting machines. Through innovation it has developed the world's first "Wholegarment" knitting machine that can very efficiently knit an entire garment, producing high quality clothes while helping to reduce waste.

 

Holdings were sold for a variety of reasons. These include reduced conviction in long-term growth prospects (Asics, Subaru, Fukuoka Financial, Zenkoku Hosho), loss of confidence in management execution abilities (Cyberdyne, Demae-can), and insufficient further upside in the shares (Gree).

 

Although there has been a set-back to the NAV of your Company, we remain optimistic about the future. Japan is an advanced democratic nation that adheres to the rule of law. Technological change creates opportunities for smaller growth companies. Your Company contains a blend of growth businesses ranging from high growth internet and automation businesses through to consumer brands and eclectic long-duration growth businesses. Given our satisfaction with the fundamental progress of the portfolio combined with what we believe to be particularly attractive valuations, we used the gearing to buy more shares in companies where we see significant upside. Consequently, the level of net gearing rose and ended the period at 16.9%. In summary, our view is that your Company has a well-diversified portfolio of quality growth companies with sound long-term prospects available at particularly attractive valuations.

 

Past performance is not a guide to future performance

 

Total return information sourced from Refinitiv/Baillie Gifford. See disclaimer at end of this document.

 

See Glossary of Terms and Alternative Performance Measures at the end of this announcement.

 

 

 

Responsibility Statement

 

We confirm that to the best of our knowledge:

 

a) the condensed set of Financial Statements has been prepared in accordance with FRS 104 'Interim Financial Reporting';

 

b) the Interim Management Report includes a fair review of the information required by Disclosure Guidance and Transparency Rule 4.2.7R (being an indication of important events that have occurred during the first six months of the financial year, their impact on the condensed set of Financial Statements and a description of the principal risks and uncertainties for the remaining six months of the year); and

 

c) the Interim Financial Report includes a fair review of the information required by Disclosure Guidance and Transparency Rule 4.2.8R (disclosure of related party transactions and changes therein).

 

On behalf of the Board

J Keith R Falconer

Chairman

22 March 2022

 

 

 

 

Equity Portfolio by Growth Category as at 28 February 2022

 

Secular

Growth1

 

 

Growth

Stalwarts2

 

 

 

Special

Situations3

 

 

 

Cyclical Growth4

 

 

 

% of

total investments

 

% of

total investments

 

% of

total investments

 

% of

total investments

 

SBI

3.8

 

Calbee

2.8

 

SoftBank

4.7

 

Sumitomo Mitsui Trust

3.0

Rakuten

3.3

 

Shiseido

2.3

 

Inpex

3.1

 

Sumitomo Metal Mining

3.0

GMO Internet

3.2

 

Nintendo

2.1

 

MS&AD Insurance

3.0

 

Itochu

2.9

Fanuc

3.2

 

Uni Charm

1.7

 

Sony

3.0

 

Bridgestone

2.9

CyberAgent

3.0

 

Pola Orbis

1.6

 

Mixi

2.4

 

Denso

2.8

Kubota

2.6

 

Makita

0.8

 

Colopl

1.4

 

Murata Manufacturing

1.6

Misumi

2.5

 

Sugi

0.6

 

Tokyo Tatemono

1.4

 

DMG Mori

1.4

Sysmex

2.3

 

Park24

0.5

 

 

 

 

Nifco

1.4

Nidec

1.9

 

Secom

0.4

 

 

 

 

Mitsubishi Electric

1.3

Sato

1.6

 

Sawai Pharmaceutical

0.3

 

 

 

 

Rohm

1.0

MonotaRO

1.5

 

 

 

 

 

 

 

Outsourcing

0.9

Raksul

1.3

 

 

 

 

 

 

 

Iida

0.7

Mercari

1.2

 

 

 

 

 

 

 

Tsubaki Nakashima

0.6

Recruit Holdings

1.1

 

 

 

 

 

 

 

Chugoku Marine Paints

0.5

Topcon

1.0

 

 

 

 

 

 

 

Shima Seiki

0.4

SMC

1.0

 

 

 

 

 

 

 

Mazda Motor

0.3

Toyota Tsusho

0.8

 

 

 

 

 

 

 

 

 

TKP

0.8

 

 

 

 

 

 

 

 

 

Infomart

0.7

 

 

 

 

 

 

 

 

 

Keyence

0.7

 

 

 

 

 

 

 

 

 

Healios K.K.

0.7

 

 

 

 

 

 

 

 

 

GA Technologies

0.6

 

 

 

 

 

 

 

 

 

Shimano

0.6

 

 

 

 

 

 

 

 

 

Digital Garage

0.6

 

 

 

 

 

 

 

 

 

Broadleaf

0.5

 

 

 

 

 

 

 

 

 

Istyle

0.4

 

 

 

 

 

 

 

 

 

Peptidream

0.4

 

 

 

 

 

 

 

 

 

Bengo4.com

0.4

 

 

 

 

 

 

 

 

 

Noritsu Koki

0.4

 

 

 

 

 

 

 

 

 

Base

0.3

 

 

 

 

 

 

 

 

 

Nippon Ceramic

0.3

 

 

 

 

 

 

 

 

 

Rizap

0.3

 

 

 

 

 

 

 

 

 

Lifull

0.2

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

43.2

 

 

13.1

 

 

19.0

 

 

24.7

             

 

1 Secular Growth: Opportunity to grow rapidly but where there are a number of potential outcomes.

2 Growth Stalwarts: Growth is less rapid but more predictble.

3 Special Situations: Performance has not been good but there is a reason to believe improvements are underway.

4 Cyclical Growth: Earnings do not rise every year but are expected to be higher from one cycle to the next.

 

 

Twenty Largest Holdings at 28 February 2022 (unaudited)

 

Name

Business

Value

£'000

% of total investments

SoftBank

Telecom operator and technology investor

 44,357

4.7

SBI

Online financial services

 35,988

3.8

Rakuten

Internet retail and financial services

 31,468

3.3

GMO Internet

Internet conglomerate

 30,429

3.2

Fanuc

Robotics manufacturer

 29,980

3.2

Inpex

Oil and gas producer

 29,097

3.1

Sumitomo Mitsui Trust

Japanese trust bank and investment manager

 28,638

3.0

MS&AD Insurance

Insurance

 28,438

3.0

Sony

Consumer electronics, films and finance

 28,154

3.0

CyberAgent

Japanese internet advertising and content

 28,117

3.0

Sumitomo Metal Mining

Smelting and copper, nickel and gold mining

 28,032

3.0

Itochu

General trading firm

 27,248

2.9

Bridgestone

Tyre Manufacturing

 26,888

2.9

Calbee

Branded snack foods

 26,740

2.8

Denso

Auto parts

 26,614

2.8

Kubota

Agricultural machinery

 24,168

2.6

Misumi

Online distributor of precision machinery parts

 23,998

2.5

Mixi

Mobile gaming

 23,188

2.4

Sysmex

Medical testing equipment

 21,597

2.3

Shiseido

Japanese cosmetics manufacturer

 21,363

2.3

Total

 

 564,502

59.8

 

 

Income Statement (unaudited)

 

 

For the six months ended

28 February 2022

For the six months ended

28 February 2021

 

Revenue

£'000

Capital

£'000

Total

£'000

Revenue

£'000

Capital

£'000

Total

£'000

Gains on sales of investments

 18,469

 18,469

-

27,969

27,969 

Movement in investment holding gains

(165,919)

(165,919)

-

120,497

120,497 

Currency gains

 2,426

 2,426

-

4,945

4,945 

Income from investments and interest receivable

 9,612

-

 9,612

8,025 

-

8,025 

Investment management fee

(2,540)

-

(2,540)

(2,696)

-

(2,696)

Other administrative expenses

(350)

-

(350)

(319)

-

(319)

Net return before finance costs and taxation

 6,722

(145,024)

(138,302)

5,010 

153,411

158,421 

Finance costs of borrowings

(886)

-

(886)

(1,083)

-

(1,083)

Net return before taxation

 5,836

(145,024)

(139,188)

3,927 

153,411

157,338 

Tax

(961)

-

(961)

(802)

-

(802)

Net return after taxation

 4,875

(145,024)

(140,149)

3,125 

153,411

156,536 

Net return per ordinary share (note 5)

 5.17p

(153.74p)

(148.57p)

3.40p

166.88p

170.28p

 

The total column of this statement is the profit and loss account of the Company. The supplementary revenue and capital columns are prepared under guidance published by the Association of Investment Companies.

All revenue and capital items in this statement derive from continuing operations.

A Statement of Comprehensive Income is not required as all gains and losses of the Company have been reflected in the above statement.

 

 

 

Balance Sheet (unaudited)

 

 

At 28 February 2022

£'000

At 31 August 2021

£'000

Fixed assets

 

 

Investments held at fair value through profit or loss (note 6)

944,570

1,053,673

Current assets

 

 

Debtors

4,388

2,111

Cash and cash equivalents

2,478

44,289

 

6,866

46,400

Creditors

 

 

Amounts falling due within one year

(2,717)

(2,471)

Net current assets

4,149

43,929

Total assets less current liabilities

948,719

1,097,602

Creditors

 

 

Amounts falling due after more than one year:

 

Bank loans (note 7)

(139,126)

(142,200)

Net assets

809,593 

955,402

Capital and reserves

 

 

Share capital

4,717

4,717

Share premium

213,902

213,902

Capital redemption reserve

203

203

Capital reserve

580,787

725,811

Revenue reserve

9,984

10,769

Shareholders' funds

809,593

955,402

Net asset value per ordinary share*

858.3p

1,012.8p

Ordinary shares in issue (note 8)

94,328,209

94,238,209

*See Glossary of Terms and Alternative Performance Measures at the end of this announcement.

 

 

 

Statement of Changes in Equity (unaudited)

 

For the six months ended 28 February 2022

 

Sharecapital

£'000

Share premium

£'000

Capital redemption reserve

£'000

Capital

reserve*

£'000

Revenue reserve

£'000

Shareholders'funds

£'000

Shareholders' funds at 1 September 2021

 4,717

 213,902

 203

 725,811

 10,769

 955,402

Net return after taxation

 -

 -

 -

(145,024)

 4,875 

(140,149)

Dividends paid during the period (note 4)

 -

 -

 -

 -

(5,660)

(5,660)

Shareholders' funds at 28 February 2022

 4,717

 213,902

 203

 580,787

 9,984

 809,593

 

For the six months ended 28 February 2021

 

Sharecapital

£'000

Share premium

£'000

Capital redemption reserve

£'000

Capital

reserve*

£'000

Revenue reserve

£'000

Shareholders'funds

£'000

Shareholders' funds at 1 September 2020

4,621

190,939

203

569,059

7,567 

772,389 

Shares issued

12

5,478

-

3,429

-

8,919 

Net return after taxation

-

-

-

153,411

3,125 

156,536 

Dividends paid during the period (note 4)

-

-

-

-

(4,134)

(4,134)

Shareholders' funds at 28 February 2021

4,633

196,417

203

725,899

6,558 

933,710 

* The capital reserve balance as at 28 February 2022 includes investment holding gains on investments of £164,930,000 (28 February 2021 - gains of £344,842,000).

 

 

Condensed Cash Flow Statement (unaudited)

 

 

Six months to

28 February 2022

£'000

Six months to

28 February 2021

£'000

Cash flows from operating activities

 

 

Net return on ordinary activities before taxation

(139,188)

157,338 

Net losses/(gains) on investments

 147,450

(148,466)

Currency gains

(2,426)

(4,945)

Finance costs of borrowings

 886

1,083 

Overseas withholding tax

(839)

(729)

Changes in debtors and creditors

(1,439)

(562)

Cash from operations

 4,444

3,719 

Interest paid

(913)

(1,096)

Net cash inflow from operating activities

3,531

2,623 

Cash flows from investing activities

 

 

Acquisitions of investments

 (129,815)

(139,300)

Disposals of investments

90,781

77,207 

Exchange differences

(7)

636 

Net cash outflow from investing activities

(39,041)

(61,457)

Shares issued (note 8)

 -

8,919 

Equity dividends paid (note 4)

(5,660)

(4,134)

Net cash (outflow)/inflow from financing activities

(5,660)

4,785 

Increase in cash and cash equivalents

(41,170)

(54,049)

Exchange movements

(641)

(3,948)

Cash and cash equivalents at start of period*

 44,289

118,742 

Cash and cash equivalents at end of period*

2,478

60,745 

* Cash and cash equivalents represent cash at bank and short term money market deposits repayable on demand.

 

Notes to the Condensed Financial Statements (unaudited)

 

1. Basis of Accounting

The condensed Financial Statements for the six months to 28 February 2022 comprise the statements set out on the previous pages together with the related notes below. They have been prepared in accordance with FRS 104 'Interim Financial Reporting' and the AIC's Statement of Recommended Practice issued in November 2014 and updated in October 2019 and April 2021 with consequential amendments. They have not been audited or reviewed by the Auditor pursuant to the Auditing Practices Board Guidance on 'Review of Interim Financial Information'. The Financial Statements for the six months to 28 February 2022 have been prepared on the basis of the same accounting policies as set out in the Company's Annual Report and Financial Statements at 31 August 2021.

Going Concern

Having considered the Company's principal risks and uncertainties, as set out on the inside front cover, together with its current position, investment objective and policy, its assets and liabilities, and projected income and expenditure, together with the Company's dividend policy, it is the Directors' opinion that the Company has adequate resources to continue in operational existence for the foreseeable future. The Board has, in particular, considered the heightened market volatility due to the Russian invasion of Ukraine and the ongoing coronavirus (Covid-19) pandemic but does not believe the Company's going concern status is affected. The Company's assets, the majority of which are investments in quoted securities which are readily realisable, exceed its liabilities significantly. All borrowings require the prior approval of the Board. Gearing levels and compliance with borrowing covenants are reviewed by the Board on a regular basis. In accordance with the Company's Articles of Association, shareholders have the right to vote annually at the Annual General Meeting on whether to continue the Company. The next continuation vote will be in December 2022. The Directors have no reason to believe that the continuation resolution will not be passed at the Annual General Meeting. The Company has continued to comply with the investment trust status requirements of section 1158 of the Corporation Tax Act 2010 and the Investment Trust (Approved Company) (Tax) Regulations 2011. Accordingly, the Directors consider it appropriate to adopt the going concern basis of accounting in preparing these Financial Statements and confirm that they are not aware of any material uncertainties which may affect the Company's ability to continue to do so over a period of at least twelve months from the date of approval of these Financial Statements.

2. Financial Information

The financial information contained within this Interim Financial Report does not constitute statutory accounts as defined in sections 434 to 436 of the Companies Act 2006. The financial information for the year ended 31 August 2021 has been extracted from the statutory accounts which have been filed with the Registrar of Companies. The Auditor's Report on those accounts was not qualified, did not include a reference to any matters to which the Auditor drew attention by way of emphasis without qualifying its report and did not contain statements under sections 498(2) or (3) of the Companies Act 2006.

3. Investment Manager

Baillie Gifford & Co Limited, a wholly owned subsidiary of Baillie Gifford & Co, has been appointed by the Company as its Alternative Investment Fund Manager and Company Secretary. The investment management function has been delegated to Baillie Gifford & Co. The management agreement can be terminated on not less than 6 months' notice, or on shorter notice in certain circumstances. The annual management fee is 0.75% on the first £50 million of net assets, 0.65% on the next £200 million of net assets and 0.55% on the remaining net assets, calculated and payable quarterly.

4. Dividends

 

Six months to 28 February 2022

£'000

Six months to 28 February 2021

£'000

Amounts recognised as distribution in the period:

 

 

Previous year's final dividend of 6.00p paid 21 December 2021

(2021- 4.50p paid 11 December 2020)

 

5,660

 

4,134

No interim dividend has been declared.

5. Net return per ordinary share

 

Six months to

28 February 2022

£'000

Six months to

298 February 2021

 £'000

Revenue return after taxation

4,875

3,125

Capital return after taxation

(145,024)

153,411

Total net return

(140,149)

156,536

Weighted average number of ordinary shares in issue

94,328,209 

91,929,766

Net return per ordinary share is based on the above totals of revenue and capital and the weighted average number of ordinary shares in issue during each period. There are no dilutive or potentially dilutive shares in issue.

6. Fair Value

The fair value hierarchy used to analyse the basis on which the fair values of financial instruments held at fair value through the profit or loss account are measured is described below. Fair value measurements are categorised on the basis of the lowest level input that is significant to the fair value measurement.

Level 1 - using unadjusted quoted prices for identical instruments in an active market;

Level 2 - using inputs, other than quoted prices included within Level 1, that are directly or indirectly observable (based on market data); and

Level 3 - using inputs that are unobservable (for which market data is unavailable).

The fair value of listed investments is the last traded price which is equivalent to the bid price on Japanese markets.

The financial assets designated as valued at fair value through profit or loss are all categorised as Level 1 in the above hierarchy. None of the financial liabilities are designated at fair value through profit or loss in the Financial Statements.

All of the Company's investments fall into Level 1 for the periods reported.

7. Bank Loans

Bank loans of £139.1 million (¥21.5 billion) have been drawn down under yen loan facilities which are repayable between August 2023 and November 2024 (31 August 2021 - £142.2 million (¥21.5 billion)).

8. Share Capital

The Company has the authority to issue shares/sell treasury shares at a premium to net asset value as well as to buy back shares at a discount to net asset value.

During the period, no shares were issued (28 February 2021 - 815,000 shares (of which 556,716 came from treasury) were issued at a premium to net asset value raising net proceeds of £8,919,000). There were no shares held in treasury at 28 February 2022 (28 February 2021 - nil).

During the period to 28 February 2022, no ordinary shares were bought back into treasury (2021 - no shares were bought back). As at 28 February 2022 the Company has authority remaining to buy back 14,139,798 ordinary shares.

9. Transaction Costs

Transaction costs incurred on the purchase and sale of the investments are added to the purchase cost or deducted from the sales proceeds, as appropriate. During the period, transaction costs on purchases amounted to £48,000 (28 February 2021 - £40,000) and transaction costs on sales amounted to £50,000 (28 February 2021 - £40,000).

 

10. Related Party Transactions

There have been no transactions with related parties during the first six months of the current financial year that have materially affected the financial position or the performance of the Company during that period and there have been no changes in the related party transactions described in the last Annual Report and Financial Statements that could have had such an effect on the Company during that period.

 

11. Principal Risks and Uncertainties

The principal risks facing the Company are financial risk, investment strategy risk, discount risk, regulatory risk, environmental, social and governance (ESG) risk, custody and depositary risk, smaller company risk, operational risk, leverage risk, political and associated economic risk, cyber security risk and emerging risks. An explanation of these risks and how they are managed is set out on pages 8 and 9 of the Company's Annual Report and Financial Statements for the year to 31 August 2021 and is available on the Company's website: japantrustplc.co.uk.

The principal risks and uncertainties have not changed since the date of the Annual Report. Further details on the Company's risks can be found on pages 14 and 15 of the Interim Financial Report.

 

Glossary of Terms and Alternative Performance Measures (APM)

 

Total Assets

Total assets less current liabilities, before deduction of all borrowings at par value.

 

Net Asset Value

Also described as shareholders' funds, Net Asset value (NAV) is the value of total assets less liabilities (including borrowings at par value). The NAV per share is calculated by dividing this amount by the number of ordinary shares in issue. Borrowings are valued at their nominal par value. Par value approximates to amortised cost. The Company's yen denominated loans are valued at their sterling equivalent.

 

Net Current Assets

Net current assets comprise current assets less current liabilities, excluding long-term borrowings at par value.

 

(Discount)/Premium (APM)

As stockmarkets and share prices vary, an investment trust's share price is rarely the same as its NAV. When the share price is lower than the NAV per share it is said to be trading at a discount. The size of the discount is calculated by subtracting the share price from the NAV per share and is usually expressed as a percentage of the NAV per share. If the share price is higher than the NAV per share, this situation is called a premium.

 

 

 

28 February 2022

31 August 2021

Net Asset Value per ordinary share

(a)

858.3p

1,012.8p

Share price

(b)

830.0p

1,022.0p

(Discount)/premium ((b-a) ÷ (a)) expressed as a percentage

(3.3%)

0.9%

 

Total Return (APM)

The total return is the return to shareholders after reinvesting the net dividend on the date that the share price goes ex-dividend.

 

 

 

Feb

2022

NAV

(par)

Feb

2022

Share

price

Feb

2021

NAV

(par

Feb

2021

Share

price

Closing NAV per share/share price

(a)

858.3p

830.0p

 

1,007.5p

 

1,060.0p

Dividend adjustment factor*

(b)

1.0058

1.0059

 

1.0046

 

1.0046

Adjusted closing NAV per share/share price

(c) = (a) x (b)

863.3p

834.9p

 

1,012.1p

 

1,064.9p

Opening NAV per share/share price

(d)

1,012.8p

1,022.0p

 

840.8p

 

817.0p

Total Return

((c ÷ d) - 1)

(14.8%)

(18.3%)

20.4%

30.3%

* The dividend adjustment factor is calculated on the assumption that the dividend of 6.00p (2021 - 4.50p) paid by the Company in the period under review was invested into shares of the Company at the cum income NAV per share/share price, as appropriate, at the ex-dividend date.

 

Gearing (APM)

At its simplest, gearing is borrowing. Just like any other public company, an investment trust can borrow money to invest in additional investments for its portfolio. The effect of the borrowing on the shareholders' assets is called 'gearing'. If the Company's assets grow, the shareholders' assets grow proportionately more because the debt remains the same. But if the value of the Company's assets falls, the situation is reversed. Gearing can therefore enhance performance in rising markets but can adversely impact performance in falling markets.

Gearing is the Company's borrowings at par less cash and cash equivalents expressed as a percentage of shareholders' funds.

Potential gearing is the Company's borrowings at par expressed as a percentage of shareholders' funds.

 

Leverage (APM)

For the purposes of the Alternative Investment Fund Managers (AIFM) Regulations, leverage is any method which increases the Company's exposure, including the borrowing of cash and the use of derivatives. It is expressed as a ratio between the Company's exposure and its net asset value and can be calculated on a gross and a commitment method. Under the gross method, exposure represents the sum of the Company's positions after the deduction of sterling cash balances, without taking into account any hedging and netting arrangements. Under the commitment method, exposure is calculated without the deduction of sterling cash balances and after certain hedging and netting positions are offset against each other.

 

Active Share (APM)

Active share, a measure of how actively a portfolio is managed, is the percentage of the portfolio that differs from its comparative index. It is calculated by deducting from 100 the percentage of the portfolio that overlaps with the comparative index. An active share of 100 indicates no overlap with the index and an active share of zero indicates a portfolio that tracks the index.

 

Further Shareholder Information

 

 

The Baillie Gifford Japan Trust aims to achieve long term capital growth principally through investment in medium and smaller sized Japanese companies which are believed to have above average prospects for growth, although it invests in larger companies when considered appropriate. At 28 February 2022, the Company had total assets of £948.7m (before deduction of bank loans of £139.1m).

The Company is managed by Baillie Gifford, an Edinburgh based fund management group with around £267.5bn under management and advice as at 22 March 2022.

Past performance is not a guide to future performance. The value of an investment and any income from it is not guaranteed and may go down as well as up and investors may not get back the amount invested. This is because the share price is determined by the changing conditions in the relevant stock markets in which the Company invests and by the supply and demand for the Company's shares. You should view your investment as long term. You can find up to date performance information about The Baillie Gifford Japan Trust PLC on the Company website at japantrustplc.co.uk.†

 

The Interim Financial Report is available at japantrustplc.co.uk and will be posted to shareholders on or around 8 April 2022.

 

22 March 2022

 

For further information please contact:

Alex Blake, Baillie Gifford & Co

Tel: 0131 275 2859

 

Mark Knight, Four Communications

Tel: 0203 697 4200 or 07803 758810

 

None of the views expressed in this document should be construed as advice to buy or sell a particular investment.

Neither the contents of the Managers' website nor the contents of any website accessible from hyperlinks on the Managers' website (or any other website) is incorporated into, or forms part of, this announcement.

 

Third Party Data Provider Disclaimer

 

No third party data provider ('Provider') makes any warranty, express or implied, as to the accuracy, completeness or timeliness of the data contained herewith nor as to the results to be obtained by recipients of the data. No Provider shall in any way be liable to any recipient of the data for any inaccuracies, errors or omissions in the index data included in this document, regardless of cause, or for any damages (whether direct or indirect) resulting therefrom.

No Provider has any obligation to update, modify or amend the data or to otherwise notify a recipient thereof in the event that any matter stated herein changes or subsequently becomes inaccurate.

Without limiting the foregoing, no Provider shall have any liability whatsoever to you, whether in contract (including under an indemnity), in tort (including negligence), under a warranty, under statute or otherwise, in respect of any loss or damage suffered by you as a result of or in connection with any opinions, recommendations, forecasts, judgements, or any other conclusions, or any course of action determined, by you or any third party, whether or not based on the content, information or materials contained herein.

 

- Ends -

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR PPUBPWUPPGRP
Date   Source Headline
7th May 202412:18 pmRNSNet Asset Value(s)
7th May 202411:36 amRNSNet Asset Value(s)
3rd May 202412:53 pmRNSNet Asset Value(s)
2nd May 202411:03 amRNSNet Asset Value(s)
1st May 20243:21 pmRNSNet Asset Value(s)
1st May 202411:59 amRNSTotal Voting Rights
30th Apr 202412:02 pmRNSNet Asset Value(s)
29th Apr 202412:16 pmRNSNet Asset Value(s)
26th Apr 20245:09 pmRNSTransaction in Own Shares
26th Apr 202411:57 amRNSNet Asset Value(s)
25th Apr 20244:59 pmRNSTransaction in Own Shares
25th Apr 202411:34 amRNSNet Asset Value(s)
24th Apr 202412:41 pmRNSNet Asset Value(s)
23rd Apr 20245:02 pmRNSTransaction in Own Shares
23rd Apr 202412:15 pmRNSNet Asset Value(s)
22nd Apr 202412:21 pmRNSNet Asset Value(s)
19th Apr 20244:52 pmRNSTransaction in Own Shares
19th Apr 20241:26 pmRNSNet Asset Value(s)
18th Apr 202411:26 amRNSNet Asset Value(s)
17th Apr 20245:06 pmRNSTransaction in Own Shares
17th Apr 202412:10 pmRNSNet Asset Value(s)
16th Apr 20243:40 pmRNSNet Asset Value(s)
15th Apr 20245:03 pmRNSTransaction in Own Shares
15th Apr 202412:08 pmRNSNet Asset Value(s)
12th Apr 20245:16 pmRNSTransaction in Own Shares
12th Apr 202411:37 amRNSNet Asset Value(s)
11th Apr 20244:59 pmRNSTransaction in Own Shares
11th Apr 20244:31 pmRNSHolding(s) in Company
11th Apr 202411:13 amRNSNet Asset Value(s)
10th Apr 20244:52 pmRNSTransaction in Own Shares
10th Apr 202412:06 pmRNSNet Asset Value(s)
9th Apr 202411:24 amRNSNet Asset Value(s)
8th Apr 20244:59 pmRNSTransaction in Own Shares
8th Apr 202411:06 amRNSNet Asset Value(s)
5th Apr 202412:05 pmRNSNet Asset Value(s)
5th Apr 202412:05 pmRNSTransaction in Own Shares - Correction
4th Apr 20245:18 pmRNSTransaction in Own Shares
4th Apr 202411:21 amRNSNet Asset Value(s)
3rd Apr 202411:19 amRNSNet Asset Value(s)
2nd Apr 20245:06 pmRNSTransaction in Own Shares
2nd Apr 20244:35 pmRNSNet Asset Value(s)
2nd Apr 20243:20 pmRNSNet Asset Value(s)
2nd Apr 20243:00 pmRNSTotal Voting Rights
2nd Apr 20242:32 pmRNSNet Asset Value(s)
28th Mar 20245:01 pmRNSTransaction in Own Shares
28th Mar 202411:45 amRNSNet Asset Value(s)
27th Mar 20244:54 pmRNSTransaction in Own Shares
27th Mar 202411:53 amRNSNet Asset Value(s)
26th Mar 20245:08 pmRNSTransaction in Own Shares
26th Mar 202411:46 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.